Data Bridge Market Research

Qualitative Market Research on Molecular Modelling Market with Player Forecast Like Simulations Plus, Indigo Instru., Advanced Chemistry Development, Certara & More

Molecular Modelling Market Research Industry Trends Analysis


Pune, India -- (SBWIRE) -- 03/16/2018 -- The Global Molecular Modelling Market accounted to grow at a CAGR of 15.8% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Also the Global Molecular Modelling Market By Approach (Molecular Mechanics Approach, Quantum Chemistry Approach), By Product (Instruments, Reagents, Kits), By Application (Drug Development, Drug Discovery {Direct Drug Design, Indirect Drug Design, Molecular Mimicry}), By End User (Pharmaceutical & Biotechnological Companies, Research Organizations), By Geography – Industry Trends and Forecast to 2024.

Molecular modelling is the key aspect of medicinal chemistry in drug designing process. The modelling describes the three-dimensional structures of molecules, physic-chemical properties, generation or manipulation. This is also used in drug design, computational biology, computational chemistry, and materials science. The procedure involves wide array of computerized techniques based on theoretical chemistry methods and experimental data to analyze the biological and molecular property.

Get Free Sample Research Report:

Major Market Drivers and Restraints:

- Increase in better drug treatment.
- Rise in varied diseases, leads to drug development.
- Increased investment of biotechnology and pharmaceutical industries in R&D.
- Technological advancements in drug design.
- Progress in the biology and biosimilars markets.
- High cost of the research & development hampers the market.

Market Segmentation: Global Molecular Modelling Market
The global molecular modelling market is segmented by approach into molecular mechanics approach and quantum chemistry approach.

On the basis of product the market is segmented into instruments, reagents, kits and others.
On the basis of application the market is segmented into drug development, drug discovery and other application. The drug discovery is further sub segmented into direct drug design, indirect drug design and molecular mimicry. The direct drug design is again sub-segmented into lead identification, target identification and others. The indirect drug design is again sub-segmented into pharmacophore, quantitative structure-activity relationships (QSAR) and others.

On the basis of end user the market is segmented into pharmaceutical & biotechnological companies, research organizations and others.

On the basis of geography, molecular modelling market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.

Speak to Research Analyst for Further Query:

Competitive Analysis: Global Molecular Modelling Market

The molecular modelling market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of molecular modelling market for global, Europe, North America, Asia Pacific and South America.

Major Market Competitors: Global Molecular Modelling Market

Some of the major players operating in molecular modelling market are Thermo Fisher Scientific Inc., Simulations Plus, Inc., Indigo Instruments, Advanced Chemistry Development, Inc., Certara, L.P., Dassault Systèmes, Schrödinger, LLC, Physiomics PLC, Genedata AG, Chemical Computing Group ULC, Rosa & Co., LLC., Agile Molecule, Acellera Ltd., Bioinformatics LLC., Bruker, Biomax Informatics AG, QIAGEN, Molecular Models Company, F. Hoffmann-La Roche Ltd. and INTELLIGENT PHARMA among others.

Want Full Report? Enquire Here: